NO943988L - 7-disubstituert-metyl-4-okso-3H,5H-pyrrolo-(3,2-d)pyrimidin og farmasöytiske anvendelser og preparater inneholdende samme - Google Patents

7-disubstituert-metyl-4-okso-3H,5H-pyrrolo-(3,2-d)pyrimidin og farmasöytiske anvendelser og preparater inneholdende samme

Info

Publication number
NO943988L
NO943988L NO943988A NO943988A NO943988L NO 943988 L NO943988 L NO 943988L NO 943988 A NO943988 A NO 943988A NO 943988 A NO943988 A NO 943988A NO 943988 L NO943988 L NO 943988L
Authority
NO
Norway
Prior art keywords
pyrrolo
disubstituted
pyrimidine
oxo
methyl
Prior art date
Application number
NO943988A
Other languages
English (en)
Other versions
NO943988D0 (no
NO303637B1 (no
Inventor
Shir Niwas
Iii John A Secrist
John A Montgomery
Original Assignee
Biocryst Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocryst Pharm Inc filed Critical Biocryst Pharm Inc
Publication of NO943988D0 publication Critical patent/NO943988D0/no
Publication of NO943988L publication Critical patent/NO943988L/no
Publication of NO303637B1 publication Critical patent/NO303637B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/01Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/32Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
    • C07C255/35Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by halogen atoms, or by nitro or nitroso groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/01Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/32Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
    • C07C255/40Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by doubly-bound oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/01Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/32Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
    • C07C255/42Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being further bound to other hetero atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO943988A 1992-04-21 1994-10-20 7-disubstituert-metyl-4-okso-3H,5H-pyrrolo-£3,2-d|pyrimidin, farmas°ytisk preparat, og anvendelse derav NO303637B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US87144192A 1992-04-21 1992-04-21
PCT/US1993/002841 WO1993021187A1 (en) 1992-04-21 1993-03-25 7-DISUBSTITUTED-METHYL-4-OXO-3H^_,5H^_-PYRROLO[3,2-d^_]PYRIMIDINE AND PHARMACEUTICAL USES AND COMPOSITIONS CONTAINING THE SAME

Publications (3)

Publication Number Publication Date
NO943988D0 NO943988D0 (no) 1994-10-20
NO943988L true NO943988L (no) 1994-10-20
NO303637B1 NO303637B1 (no) 1998-08-10

Family

ID=25357439

Family Applications (1)

Application Number Title Priority Date Filing Date
NO943988A NO303637B1 (no) 1992-04-21 1994-10-20 7-disubstituert-metyl-4-okso-3H,5H-pyrrolo-£3,2-d|pyrimidin, farmas°ytisk preparat, og anvendelse derav

Country Status (10)

Country Link
EP (1) EP0638080A4 (no)
JP (1) JPH07507062A (no)
KR (1) KR950701335A (no)
AU (1) AU4276693A (no)
CA (1) CA2133346A1 (no)
FI (1) FI944933A0 (no)
HU (1) HUT71559A (no)
NO (1) NO303637B1 (no)
RU (1) RU94046387A (no)
WO (1) WO1993021187A1 (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0986563A1 (en) * 1997-05-29 2000-03-22 Novartis AG 2-amino-7-(1-substituted-2-hydroxyethyl)-3,5-dihydro-pyrrolo 3,2-d]pyrimidin-4-ones
US6355244B1 (en) 1997-11-17 2002-03-12 University Of Kentucky Research Foundation Methods and compositions for the treatment of psoriasis
US6174888B1 (en) 1998-05-28 2001-01-16 Novartis Ag 2-amino-7-(1-substituted-2-hydroxyethyl)-3,5-dihydropyrrolo[3,2-D]pyrimidin-4-ones
GB0215392D0 (en) * 2002-07-03 2002-08-14 Glaxo Group Ltd Chemical compounds
CA2536887C (en) * 2003-08-26 2012-03-06 Teijin Pharma Limited Pyrrolopyrimidinone derivatives
US7557113B2 (en) 2003-08-26 2009-07-07 Teijin Pharma Limited Substituted pyrrolo[3,2-d]pyrimidine derivatives
MY140748A (en) 2004-12-06 2010-01-15 Astrazeneca Ab Novel pyrrolo [3,2-d] pyrimidin-4-one derivatives and their use in therapy
US7763257B2 (en) 2004-12-09 2010-07-27 Christina Juneau Compositions comprising transforming growth factor (TGF)-β1 and TGF-β2 in admixture of proteins obtained from dairy products
EP2225226B1 (en) 2007-12-26 2016-08-17 Critical Outcome Technologies, Inc. Compounds and their use in a method for treatment of cancer
CA2730890C (en) 2008-07-17 2018-05-15 Critical Outcome Technologies Inc. Thiosemicarbazone inhibitor compounds and cancer treatment methods
EP2552915B1 (en) 2010-04-01 2017-07-19 Critical Outcome Technologies Inc. Compounds for the treatment of hiv

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT61765A (en) * 1989-10-31 1993-03-01 Biocryst Inc Process for producing purine nucleoside phosphorylase inhibitors and pharmaceutical compositions comprising same as active ingredient
US5189039A (en) * 1989-11-29 1993-02-23 Biocryst, Inc. 7-disubstituted-methyl-4-oxo-3H,5H-pyrrolo[3,2d]pyrimidine and pharmaceutical uses and compositions containing the same

Also Published As

Publication number Publication date
NO943988D0 (no) 1994-10-20
WO1993021187A1 (en) 1993-10-28
EP0638080A4 (en) 1995-08-23
EP0638080A1 (en) 1995-02-15
JPH07507062A (ja) 1995-08-03
HUT71559A (en) 1995-12-28
FI944933A (fi) 1994-10-20
RU94046387A (ru) 1996-09-27
AU4276693A (en) 1993-11-18
KR950701335A (ko) 1995-03-23
FI944933A0 (fi) 1994-10-20
CA2133346A1 (en) 1993-10-28
NO303637B1 (no) 1998-08-10
HU9403021D0 (en) 1994-12-28

Similar Documents

Publication Publication Date Title
NO305952B1 (no) 1,5-benzodiazepinderivater, anvendelse derav og farmasoeytiske preparater
IL89974A0 (en) Aryl and heteroaryl bicyclodiones,their preparations and their use as herbicides
AU8405991A (en) Pyrimidine derivative and medicine
NO930677L (no) Farmasoeytiske forbindelser
AU7809891A (en) 2,4-diamino-6-(2-chlorophenyl)pyrimidines and use in medicine
PH27460A (en) Pyrimidine derivatives and herbicidal composition containing the same
DE3677445D1 (de) 2-substituierte-e-kondensierte(1,5-c)-pyrimidine, pharmazeutische zubereitungen und ihre verwendung.
ZA941993B (en) Amidine derivatives containing heterocyclic groups the preparation and use thereof
BR9207062A (pt) Formulação em comprimido
NO943988L (no) 7-disubstituert-metyl-4-okso-3H,5H-pyrrolo-(3,2-d)pyrimidin og farmasöytiske anvendelser og preparater inneholdende samme
DE69429514D1 (de) Antiparasitäre präparate
AU9044091A (en) Pharmaceuticals
AU8072691A (en) Pharmaceutical preparations
BR9605046B1 (pt) compostos n-(pirimidinl)-benzenossulfonamida e preparação farmacêutica contendo as mesmas.
AU8099691A (en) Pyrimidinyl and triazinyl herbicides
DK334989D0 (da) Antivirale forbindelser og farmaceutiske praeparater med indhold af saadanne.
NO951350D0 (no) Farmasöytiske preparater inneholdende 3-substituerte 2-oksindol-1-karboksamider
IL88854A0 (en) Pyrimidine and purine 1,2-butadiene-4-ol derivatives and pharmaceutical compositions containing the same
ITMI932019A0 (it) Composizione farmaceutica antivirale contenente la 2-ammino 4,6-dicloropirimidina e metisoprinolo
NO179907C (no) Benzokinoksaliner og farmasöytiske preparater inneholdende de samme
IL106938A0 (en) Pyrimidine derivatives and their use as herbicides
IT9048026A0 (it) Preparato farmaceutico e/o cosmetico.
AU7654181A (en) 5-hydroxy-5h-(1)benzopyranon(4,3-d) pyrimidines and pharmaceutical preparations
KR950000305U (ko) 햄먹(hammock)
DE59403371D1 (de) Polyisocyanat-Zubereitungen